Pharma& Biotech companies

pharma& is a privately owned global pharmaceutical company headquartered in Vienna, Austria, that specializes in the acquisition and revitalization of established specialty medicines. Founded in 2017, the company focuses on 'evergreening' proven therapies that have been deprioritized by larger pharmaceutical firms, ensuring continued patient access and exploring new clinical potential. Its portfolio features high-profile brands such as Rubraca (rucaparib) for oncology and Pegasys (peginterferon alfa-2a) for viral hepatitis and rare hematological conditions. pharma& operates a fully integrated business model, encompassing research, development, in-house API manufacturing through its subsidiary Loba biotech, and global distribution via an extensive network of subsidiaries and strategic partnerships.